| ISHARES S&P 500 HEALTH CARE SECTOR UCITS ETF USD (ACC) | RVI SALUD | 30,64% | 33,01% | 53,06% | 187,52% |
| JPM EMERGING MARKETS OPPORTUNITIES D (ACC) USD | RVI EMERGENTES CRECIMIENTO | 30,64% | 66,16% | 25,76% | 98,47% |
| CT (LUX) AMERICAN EXTENDED ALPHA 1U USD | RENT. ABSOLUTA. | 30,63% | 67,17% | 53,01% | · |
| MAN JAPAN COREALPHA EQUITY I H EUR NET-DIS A | RVI JAPÓN | 30,63% | 91,90% | 174,36% | 250,29% |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO A SGD | RVI EMERGENTES CRECIMIENTO | 30,62% | 69,74% | 31,54% | 86,89% |
| AZVALOR LUX SICAV - ALTUM FAITH - CONSISTENT EQUITY-I | RVI GLOBAL | 30,62% | 41,79% | 98,58% | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 30,62% | 37,65% | -18,10% | · |
| JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION A2 USD | RVI TECNOLOGÍA | 30,62% | 111,89% | 93,06% | 523,43% |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) M CAP | RVI EMERGENTES | 30,62% | 82,77% | 31,69% | · |
| CT (LUX) GLOBAL EMERGING MARKET EQUITIES 8U USD | RVI EMERGENTES | 30,61% | 76,56% | 18,46% | · |
